AAAAAA

   
Results: 1-10 |
Results: 10
ANIMAL PHARMACOKINETICS OF INOGATRAN, A LOW-MOLECULAR-WEIGHT THROMBININHIBITOR WITH POTENTIAL USE AS AN ANTITHROMBOTIC DRUG
Authors: ERIKSSON UG RENBERG L BREDBERG U TEGERNILSSON AC REGARDH CG
Citation: Ug. Eriksson et al., ANIMAL PHARMACOKINETICS OF INOGATRAN, A LOW-MOLECULAR-WEIGHT THROMBININHIBITOR WITH POTENTIAL USE AS AN ANTITHROMBOTIC DRUG, Biopharmaceutics & drug disposition, 19(1), 1998, pp. 55-64
A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY
Authors: GRIP L FRISON L WALLENTIN L DELLBORG M GRANDE P HALINEN M HELD P MYHRE E RYDEN L SWAHN E SWEDBERG K THYGESEN K SLEIGHT P WILHELMSEN L NASLUND U GUNDERSEN T FISCHERHANSEN J LEHTO S BARRET M NILSSON JE TEGERNILSSON AC THORSEN M ANDERSEN F LUNDSTROM M HILDEBRAND A DEFLONOLSSON C FORSBY M ISBERG P LARSSON C NORGAARD B RASMUSSEN S VIDEBAEK J KLARLUND K LANDORPH A NIELSEN T AGNER E HOJGAARD MV HELQVIST S RASMUSSEN SL EGSTRUP K MYGIND L HANSEN JF SAJADIEH A GILL S HAGHFELT T MARKENVARD J THOMASSEN A JENSEN N PETERSEN J JENSEN G FISCHER T SIPILA R KIILAVUORI K HAMALAINEN L NURMINEN J MELIN J KOSKELA E HURME H VAUHONEN I HONKANEN T UTRIANEN S HAMALAINEN T LILJA M UKKOLVA O KIVELA H SODERSTROM S POHJOLASINTONEN S HUSSI E LARSEN A FALANG JE SCHARTUMHANSEN H PAULSEN A OMLAND T HOLM T EDVARDSEN T THYBO NK HAEREM J KAPELRUD H WAAGE K ROSSEBO B HAFSOY K HAMMARSTROM E ASTROM L HALL E WETTERVIK C FORSBERG SA TYGESEN H FREDRIKSSON B EKDAHL S KIHLSTROM K MAGNUSSON JO STJERNA A MARU F NILSSON H AKRAWI S SAETRE H AHLMARK G AHLBERG G LINDE B HAGSTROM L GUSTAFSSON G GUSTAVSSON PE LARSSON AC ANDERSEN K RUTER G KIERKEGAARD A HARDHAMMAR P KARLSSON JE SVENSSON O LANDGREN F HOLMBERG B RYDEN S WEINER L DANIELEWICZ M MALMROS B NICOL P JANZON M OHLIN H HANSEN O TINGBERG E NYMAN I FJELSTAD B AHLSTROM P HEDBACK B PERK J SVENNBERG L ELLSTROM J BOMAN K REMMETS J KRISTENSSON BE LINDER R HULTING J HOIJER J MOLLER BH LYCKSELL M WAHLIN M SANDSTEDT L REDFORS A BORRETZEN J OSTBERG G JOHANSSON B MORNER S LINDAHL B OLDGREN J JONSSON J NEMECZE K THORSEN S JOHANSSON PA SINNERSTAD B LARSSON LE BAND S MARSELL R
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY, European heart journal, 18(9), 1997, pp. 1416-1425
IN-VITRO EFFECTS OF INOGATRAN, A SELECTIVE LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR
Authors: TEGERNILSSON AC BYLUND R GUSTAFSSON D GYZANDER E ERIKSSON U
Citation: Ac. Tegernilsson et al., IN-VITRO EFFECTS OF INOGATRAN, A SELECTIVE LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, Thrombosis research, 85(2), 1997, pp. 133-145
EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS, THROMBOLYSIS AND BLEEDING-TIME
Authors: GUSTAFSSON D ELG M LENFORS S BORJESSON I TEGERNILSSON AC
Citation: D. Gustafsson et al., EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, IN RAT MODELS OF VENOUS AND ARTERIAL THROMBOSIS, THROMBOLYSIS AND BLEEDING-TIME, Blood coagulation & fibrinolysis, 7(1), 1996, pp. 69-79
INOGATRAN, A NOVEL DIRECT LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, GIVEN WITH, BUT NOT AFTER, TISSUE-PLASMINOGEN ACTIVATOR, IMPROVES THROMBOLYSIS
Authors: CHEN LY NICHOLS WW MATTSSON C TEGERNILSSON AC SALDEEN TGP MEHTA JL
Citation: Ly. Chen et al., INOGATRAN, A NOVEL DIRECT LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, GIVEN WITH, BUT NOT AFTER, TISSUE-PLASMINOGEN ACTIVATOR, IMPROVES THROMBOLYSIS, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1276-1283
THROMBIN INHIBITORS BASED ON KETONE DERIVATIVES OF ARGININE AND LYSINE
Authors: JONES DM ATRASH B RYDER H TEGERNILSSON AC GYZANDER E SZELKE M
Citation: Dm. Jones et al., THROMBIN INHIBITORS BASED ON KETONE DERIVATIVES OF ARGININE AND LYSINE, Journal of enzyme inhibition, 9(1), 1995, pp. 43-60
EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, ON RAT MODELS OF THROMBOSIS
Authors: GUSTAFSSON D ELG M LENFORS S BORJESSON I TEGERNILSSON AC
Citation: D. Gustafsson et al., EFFECTS OF INOGATRAN, A NEW LOW-MOLECULAR-WEIGHT THROMBIN INHIBITOR, ON RAT MODELS OF THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1319-1319
IN-VITRO PROPERTIES OF INOGATRAN, A NEW SELECTIVE LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN
Authors: TEGERNILSSON AC GYZANDER E ANDERSSON S ENGLUND M MATTSSON C ULVINGE JC GUSTAFSSON D
Citation: Ac. Tegernilsson et al., IN-VITRO PROPERTIES OF INOGATRAN, A NEW SELECTIVE LOW-MOLECULAR-WEIGHT INHIBITOR OF THROMBIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1325-1325
THROMBIN INHIBITION CONCOMITANT WITH, BUT NOT AFTER, TISSUE-PLASMINOGEN ACTIVATOR (T-PA) INFUSION REDUCES REOCCLUSION RATES AND INTRACORONARY FIBRIN DEPOSITION
Authors: MATTSSON C TEGERNILSSON AC SALDEEN TGP CHEN LY NICHOLS WW KHAN S MEHTA JL
Citation: C. Mattsson et al., THROMBIN INHIBITION CONCOMITANT WITH, BUT NOT AFTER, TISSUE-PLASMINOGEN ACTIVATOR (T-PA) INFUSION REDUCES REOCCLUSION RATES AND INTRACORONARY FIBRIN DEPOSITION, Thrombosis and haemostasis, 73(6), 1995, pp. 1342-1342
LOW-MOLECULAR-WEIGHT RECOMBINANT THROMBIN-INHIBITOR INOGATRAN IMPROVES THROMBOLYTIC EFFICACY OF TISSUE-PLASMINOGEN ACTIVATOR
Authors: MEHTA JL CHEN LY NICHOLS WW MATTSSON MC TEGERNILSSON AC SALDEEN TGP
Citation: Jl. Mehta et al., LOW-MOLECULAR-WEIGHT RECOMBINANT THROMBIN-INHIBITOR INOGATRAN IMPROVES THROMBOLYTIC EFFICACY OF TISSUE-PLASMINOGEN ACTIVATOR, Circulation, 92(8), 1995, pp. 3556-3556
Risultati: 1-10 |